Skip to main content

Table 2 Causes of chemotherapy delays due to toxicity

From: Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

 

Cycle 2 (49 pts)

Cycle 3 (47 pts)

Cycle 4 (46 pts)

Cycle 5 (44 pts)

Cycle 6 (43 pts)

Overall

Neutropenia

10

11

3

7

8

39

Thrombocytopenia

-

4

2

4

4

14

Neutropenia + Thrombocytopenia

2

2

5

3

3

15

Anemia

-

2

1

-

1

4

Anemia + Neutropenia + Thrombocytopenia

-

-

1

-

1

2

Liver toxicity

1

1

2

1

1

6

Fever

-

-

-

1

-

1

Other (not specified)

1

-

-

1

4

6

Total

14 (28.6%)

20 (42.6%)

14 (30.4%)

17 (38.6%)

22 (51.2%)

87/229 (37%)